News & Updates

Show Multimedia Only

Regular fish oil intake tied to lower T2D risk

16 Oct 2025 by

A prospective study evaluating individuals with prediabetes shows an inverse association between habitual fish oil intake and the risk of type 2 diabetes (T2D).

Regular fish oil intake tied to lower T2D risk

16 Oct 2025

Tirzepatide lowers HbA1c, BMI in youth-onset T2D

16 Oct 2025 by

Once-weekly treatment with tirzepatide significantly reduces HbA_1c levels and BMI in children and adolescents with type 2 diabetes (T2D) compared with placebo, according to the SURPASS-PEDS trial presented at EASD 2025.

Tirzepatide lowers HbA1c, BMI in youth-onset T2D

16 Oct 2025

HPV9 vaccination tied to reduced risk of juvenile idiopathic arthritis

15 Oct 2025

Nine-valent human papillomavirus (HPV9) vaccination may protect against the development of juvenile idiopathic arthritis (JIA), and this benefit persists for at least 3 years, as shown in a retrospective study.

HPV9 vaccination tied to reduced risk of juvenile idiopathic arthritis

15 Oct 2025

GLP-1RA offers protection against mortality, cardiac events for psoriasis patients

15 Oct 2025 by

Patients with psoriasis who are using glucagon-like peptide-1 receptor agonists (GLP-1RAs) appear to have lower risks of mortality and adverse cardiovascular events, according to a retrospective study.

GLP-1RA offers protection against mortality, cardiac events for psoriasis patients

15 Oct 2025

Inherited risk predicts increases in fibrosis in MASLD patients

15 Oct 2025

Genetic risk score (GRS), polygenic risk score-hepatic fat content (PRS-HFC), its adjusted version (PRS-5), and PNPLA3 genotypes alone show a significant relationship with increased fibrosis severity per decade in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), reports a study.

Inherited risk predicts increases in fibrosis in MASLD patients

15 Oct 2025

Triple negative patients with SSc-ILD at risk for disease progression

15 Oct 2025 by

Progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD) is still possible among patients who are positive for anticentromere antibody (ACA) or anti-RNA polymerase III antibody (ARA), results of a trial have shown.

Triple negative patients with SSc-ILD at risk for disease progression

15 Oct 2025

Race-neutral equation a better predictor of mortality risk in COPD patients: study

15 Oct 2025

Race-specific equations tend to overestimate the severity of airflow obstruction in patients with mild chronic obstructive pulmonary disease (COPD), suggests a Korea study.

Race-neutral equation a better predictor of mortality risk in COPD patients: study

15 Oct 2025

Once-monthly cafraglutide helps with weight loss in adults with obesity

15 Oct 2025

Once-a-month treatment with maridebart cafraglutide—a long-acting peptide–antibody conjugate that combines glucagon-like peptide-1 receptor agonism and glucose-dependent insulinotropic polypeptide receptor antagonism—results in substantial weight reduction in patients with obesity with or without type 2 diabetes, according to a phase II study.

Once-monthly cafraglutide helps with weight loss in adults with obesity

15 Oct 2025

Frontline nelitolimod plus pembrolizumab combo elicits response in advanced melanoma

14 Oct 2025

The toll-like receptor 9 agonist nelitolimod, when combined with pembrolizumab, shows promising antitumour activity in treatment-naïve patients with anti–PD-1/PD-L1 advanced melanoma, according to a phase II open-label trial.

Frontline nelitolimod plus pembrolizumab combo elicits response in advanced melanoma

14 Oct 2025

Extended-release minoxidil pill promotes hair growth in 4 months

14 Oct 2025 by

In patients with androgenetic alopecia, 4 months of treatment with the investigational extended-release oral minoxidil (VDPHL01) appears to induce superior hair growth compared with 6 months of treatment with the topical and immediate-release (IR) formulations, according to the results of a blinded retrospective Investigator Global Assessment (IGA) analysis.

Extended-release minoxidil pill promotes hair growth in 4 months

14 Oct 2025

News & Updates

Filter by Specialty:

Specialty:

Regular fish oil intake tied to lower T2D risk

Regular fish oil intake tied to lower T2D risk

Tirzepatide lowers HbA1c, BMI in youth-onset T2D

Tirzepatide lowers HbA1c, BMI in youth-onset T2D

HPV9 vaccination tied to reduced risk of juvenile idiopathic arthritis

HPV9 vaccination tied to reduced risk of juvenile idiopathic arthritis

GLP-1RA offers protection against mortality, cardiac events for psoriasis patients

GLP-1RA offers protection against mortality, cardiac events for psoriasis patients

Inherited risk predicts increases in fibrosis in MASLD patients

Inherited risk predicts increases in fibrosis in MASLD patients

Triple negative patients with SSc-ILD at risk for disease progression

Triple negative patients with SSc-ILD at risk for disease progression

Race-neutral equation a better predictor of mortality risk in COPD patients: study

Race-neutral equation a better predictor of mortality risk in COPD patients: study

Once-monthly cafraglutide helps with weight loss in adults with obesity

Once-monthly cafraglutide helps with weight loss in adults with obesity

Frontline nelitolimod plus pembrolizumab combo elicits response in advanced melanoma

Frontline nelitolimod plus pembrolizumab combo elicits response in advanced melanoma

Extended-release minoxidil pill promotes hair growth in 4 months

Extended-release minoxidil pill promotes hair growth in 4 months